Nima Etminan (University Medical Centre Mannheim, Mannheim, Germany) shares practical recommendations for his peers regarding the management of patients with unruptured intracranial aneurysms, as well as highlighting the PROTECT-U trial’s ongoing efforts to determine the benefits of low-dose aspirin in this population.
Most read
Features
